Bowen Chen
Northeast Agricultural University
15 Papers
2 Citations
Bowen Chen is an academic researcher from Northeast Agricultural University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Selenium Deficiency Promotes Oxidative Stress-Induced Mastitis via Activating the NF-κB and MAPK Pathways in Dairy Cow
TL;DR: It was verified that Se deficiency induces OS, which leads to ROS accumulation and the secretion of inflammatory factors to activate the NF-κB/MAPK signaling pathway and promote the occurrence of mastitis.
59
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
Xu Yang,Bowen Chen,Yanyu Wang,Yunchao Wang,Junyu Long,Na Zhang,Jing Xue,Ziyu Xun,Lin-Zhi Zhang,Jiamin Cheng,Jin Lei,Huishan Sun,Yiran Li,Jianzhen Lin,Fucun Xie,Dongxu Wang,Jie Pan,Ke-Xing Hu,M. Guan,Li Huo,Jie Shi,Ling-xiang Yu,Lin Zhou,Jin-Rhong Zhou,Zhenhui Lu,Xiaobo Yang,Yilei Mao,Xinting Sang,Yinying Lu,Haitao Zhao +29 more
TL;DR: Wang et al. as mentioned in this paper investigated the real-world efficacy of and prognostic factors for survival associated with lenvatinib plus PD-1 inhibitor treatment in a large cohort of Asian uHCC patients even the global LEAP-002 study failed to achieve the primary endpoints.
Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study
Ge Zhang,Bowen Chen,Xiaobo Yang,Huai-Yuan Wang,Xu Yang,Fucun Xie,Xiang-Qi Chen,Ling-xiang Yu,Jie Shi,Yin-Ying Lu,Haijian Zhao +10 more
TL;DR: Wang et al. as mentioned in this paper investigated overall survival and recurrence-free survival after radical resection in patients with hepatocellular-cholangiocarcinoma (cHCC-CCA), and the clinicopathological factors affecting prognosis in two center hospitals of China.
8
TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure
TL;DR: In this article , the combination of TKI and PD-1 inhibitors was evaluated in patients with hepatocellular carcinoma (uHCC) after sorafenib failure.
Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study
Bowen Chen,Jin Lei,Haitao Zhao,Jinghui Dong,Zhen Zeng,Yinying Lu,Ling-xiang Yu,Lin Zhou,Aiying Jia,Jiamin Cheng +9 more
TL;DR: In this article , the efficacy and safety of sorafenib- or lenvatinib-based combination therapy with PD-1 inhibitors in elderly patients aged ≥75 years with unresectable hepatocellular carcinoma (uHCC) were continually reviewed.
3